RS
TEVA icon

Rakuten Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Rakuten Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35K Sell
40
-50
-56% -$1.67K ﹤0.01% 696
2026
Q1 		$2.71K Sell
90
-1,143
-93% -$36.8K ﹤0.01% 579
2025
Q4 		$38.5K Sell
1,233
-46
-4% -$1.13K 0.01% 263
2025
Q3 		$25.8K Sell
1,279
-70
-5% -$1.23K 0.01% 295
2025
Q2 		$22.6K Sell
1,349
-113
-8% -$1.82K 0.01% 308
2025
Q1 		$22.5K Buy
1,462
+1,160
+384% +$20.7K 0.01% 297
2024
Q4 		$6.66K Sell
302
-730
-71% -$13.3K ﹤0.01% 438
2024
Q3 		$18.6K Buy
1,032
+7
+0.7% +$123 0.01% 274
2024
Q2 		$16.7K Buy
1,025
+3
+0.3% +$46 0.01% 276
2024
Q1 		$14.4K Buy
+1,022
New +$12.9K 0.01% 287

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Rakuten Securities's TEVA Position: Q2 2026 in Review

Rakuten Securities reduced its Teva Pharmaceuticals (TEVA) stake by 56% in Q2 2026, selling an estimated $1.67K and leaving 40 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #696.

Rakuten Securities first reported a position in TEVA in Q1 2024 and has held it in 10 quarters since. The position peaked at $38.5K in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Rakuten Securities held 40 shares of Teva Pharmaceuticals worth $1.35K as of Q2 2026.
  • Rakuten Securities sold 50 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.67K.
  • Teva Pharmaceuticals made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #696 holding.
  • Rakuten Securities first reported a position in Teva Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Rakuten Securities's Teva Pharmaceuticals position peaked at $38.5K in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.